TP53 and astrocytoma (excluding glioblastoma): These aberrations predominated in astrocytomas (TP53: 87.2%; ATRX: 68.6%), whereas oligodendrogliomas showed minimal TP53 (9.4%) and ATRX (3.8%) alterations.